Farida Gueniche

Farida Gueniche

Auto-generated profile, based on publicly available information

Farida Gueniche

Biochemistry Department, Dental School, Paris Descartes University, PRES Sorbonne Paris Cité, 1 rue Maurice Arnoux, Montrouge 92120, France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2011 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SKSenni Karim
Senni Karim
JPJessica Pereira
Jessica Pereira
FGFarida Gueniche
Farida Gueniche
CDChristine DELBARRE-LADRAT
Christine DELBARRE-LADRAT
CSCorinne Sinquin
Corinne Sinquin
Sylvia Colliec-JouaultSylvia Colliec-Jouault
Sylvia Colliec-Jouault
The therapeutic potential of natural bioactive compounds such as polysaccharides, especially glycosaminoglycans, is now well documented, and this activity combined with natural biodiversity will allow the development of a new generation of therapeutics. Advances in our understanding of the biosynthesis, structure and function of complex glycans from mammalian origin have shown the crucial role of this class of molecules to modulate disease processes and the importance of a deeper knowledge of structure-activity relationships. Marine environment offers a tremendous biodiversity and original polysaccharides have been discovered presenting a great chemical diversity that is largely species specific. The study of the biological properties of the polysaccharides from marine eukaryotes and marine prokaryotes revealed that the polysaccharides from the marine environment could provide a valid alternative to traditional polysaccharides such as glycosaminoglycans. Marine polysaccharides present a real potential for natural product drug discovery and for the delivery of new marine derived products for therapeutic applications.

23 April 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
KSKarim Senni
Karim Senni
FGFarida Gueniche
Farida Gueniche
SCSylvie Changotade
Sylvie Changotade
DSDominique Septier
Dominique Septier
CSCorinne Sinquin
Corinne Sinquin
Sylvia Colliec-JouaultSylvia Colliec-Jouault
Sylvia Colliec-Jouault
Biopolymers produced by marine organisms can offer useful tools for regenerative medicine. Particularly, HE800 exopolysaccharide (HE800 EPS) secreted by a deep-sea hydrothermal bacterium displays an interesting glycosaminoglycan-like feature resembling hyaluronan. Previous studies demonstrated its effectiveness to enhance in vivo bone regeneration and to support osteoblastic cell metabolism in culture. Thus, in order to assess the usefulness of this high-molecular weight polymer in tissue engineering and tissue repair, in vitro reconstructed connective tissues containing HE800 EPS were performed. We showed that this polysaccharide promotes both collagen structuring and extracellular matrix settle by dermal fibroblasts. Furthermore, from the native HE800 EPS, a low-molecular weight sulfated derivative (HE800 DROS) displaying chemical analogy with heparan-sulfate, was designed. Thus, it was demonstrated that HE800 DROS mimics some properties of heparan-sulfate, such as promotion of fibroblast proliferation and inhibition of matrix metalloproteinase (MMP) secretion. Therefore, we suggest that the HE800EPS family can be considered as an innovative biotechnological source of glycosaminoglycan-like compounds useful to design biomaterials and drugs for tissue engineering and repair.

6 November 2007 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
FFFlorence Fioretti
Florence Fioretti
CLCorinne Lebreton-DeCoster
Corinne Lebreton-DeCoster
FGFarida Gueniche
Farida Gueniche
MYMyriam Yousfi
Myriam Yousfi
PHPhilippe Humbert
Philippe Humbert
BCBernard Coulomb
Bernard Coulomb